Value-based pricing Archives -

China’s insulin plans will hit 2022 revenues, says Novo Nordisk

https://pharmaphorum.com/news/chinas-insulin-plans-will-hit-2022-revenues-says-novo-nordisk/

ICER methods could be illegal in US, claims US think tank

https://pharmaphorum.com/news/icer-methods-could-be-illegal-in-us-claims-us-think-tank/

Demonstrating value – the future for market access

https://pharmaphorum.com/views-and-analysis/demonstrating-value-future-market-access/

Realising the true potential of health wearables

https://pharmaphorum.com/views-and-analysis/realising-true-potential-health-wearables/

Search